Register entry

On Target Laboratories, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
6
Exclusivities
1
Countries
0
Exclusivity

Patents and exclusivities

6
PatentProductCoversExpiry
10881747CYTALUXpafolacianine sodiumsubstance, productAug 2033
9333270CYTALUXpafolacianine sodiumsubstance, productAug 2033
9341629CYTALUXpafolacianine sodiumsubstance, productAug 2033
9789208CYTALUXpafolacianine sodiumsubstance, productAug 2033
9254341CYTALUXpafolacianine sodiumsubstance, productOct 2033
9061057CYTALUXpafolacianine sodiumsubstance, productNov 2035
ProductExclusivityUntil
CYTALUXPAFOLACIANINE SODIUMODE-390 Orphan drugNov 2028
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
CytaluxPafolacianine injectioninjection, intravenous81052-138NDA
Enquiry

Common questions

Is On Target Laboratories, Inc. FDA approved?
On Target Laboratories, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does On Target Laboratories, Inc. make?
1 product is listed under On Target Laboratories, Inc. in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.